Anxiety, Inflammation, Stress, and Cannabinoids
Public ClinicalTrials.gov record NCT03491384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Novel Approaches to Understanding the Role of Cannabinoids and Inflammation in Anxiety
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study investigates whether the anxiolytic effects and anti-inflammatory properties of cannabis vary as a function of the ratio of CBD to THC, with the goal that these effects may shed light on the mixed data linking cannabis use and anxiety. Individuals with mild to moderate anxiety who elect to use cannabis (smoked flower or edible) will complete four weeks of observation. Participants complete cognitive tasks, a substance use history, health questionnaires concerning sleep and physical activity, and a blood draw at four different time points (Baseline, after 2 weeks of cannabis use, and immediately before and after self-administration after 4 weeks of use) with the use of a mobile pharmacology laboratory, which goes to a convenient location for each participant to self-administer their cannabis. Participants are then followed for five months to self-report on cannabis use, anxiety, subjective cognitive functioning, sleep quality, and other mental health symptoms.
Study identification
- NCT ID
- NCT03491384
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 361 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2018
- Primary completion
- Dec 29, 2022
- Completion
- May 16, 2023
- Last update posted
- Aug 26, 2025
2018 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Innovation and Creativity | Boulder | Colorado | 80304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Anxiety trials
Other public records listing Anxiety. Sorted by last update posted; newest first. Not a recommendation.
- NCT07796568: Virtual Group Therapy for IBD Patients With Anxiety and Depression Not yet recruiting
- NCT07792837: An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being Recruiting
- NCT07778433: BasketballRx: Game Changing Health Active, not recruiting
- NCT07542730: Diphenhydramine as an Adjunct to Moderate Sedation for Procedural First Trimester Abortions Recruiting
- NCT07768670: AI-Based Personalized Exercise Prescription Through Mobile Health on Physical Activity and Health Outcomes in Older Adults: A Feasibility Study Recruiting
- NCT07774481: Anxiety Skills Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03491384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2025 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03491384 live on ClinicalTrials.gov.